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ORIGINAL ARTICLE
INTRODUCTION
Recently, large cities in Indonesia have been faced
with an increasing number of drug users, especially among
teenagers. Jakarta, as the capital of Indonesia and one
of the metropolitan cities in Asia may have the biggest
problem of drug abuse in Indonesia. This city is no longer
just a transit place for drugs traffic but has become a
major target. There is no official data regarding this in
Indonesia but anecdotal reports clearly show the very
fast increment of drug use. It is estimated that the num-
ber of drug users now in Indonesia is about 2 million
people.
Drug use causes both social and medical problems.
The medical problem is not just merely the addiction but
also several diseases caused by microorganisms which
are introduced because of their high-risk behavior.  The
highest risk group is the heroin addicts who often use
non-aseptic, shared syringes and needles. Among them
the transmission of virus such as hepatitis C virus (HCV),
hepatitis B virus (HBV) and Human Immunodeficient
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ABSTRACT
A recent increase in the number of drug users particularly of heroin has been noted in the community. A
cross-sectional study on the level of transaminases as a representation of liver damage in drug users was
done in privated hospital in Jakarta. Exclusion criteria were fever, serious illness or the multiple use of
addictive drugs based on a urinary test. The hepatitis B surface antigen (HBsAg)  was examined using
reverse passive hemaglutination assay (RPHA) and the antibody of hepatitis C virus core-protein (anti-HCV)
with dipstick anti-HCV.  AST and ALT levels were determined using an automatic chemical analyzer. Of 132
patients who fulfill the criteria, 83.5 % were injection drug users (IDU). Means AST and ALT were signifi-
cantly higher in IDU. Anti-HCV positive patients with increased AST and ALT were significantly higher
compared to anti-HCV negative. The increase of transaminase was also consistent in injection drug users
although no viral marker could be detected. In conclusion, the examination of transaminases in drug users
especially IDU is important besides tests for hepatitis viral markers because there is often an increase with
or without viral infection and this can be associated with hepatocellular damage.
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Virus (HIV) is common.
In the past, there has been no published report re-
garding the impact of viral hepatitis in drug users be-
cause of the insignificant number of them in the commu-
nity or hospitals. A relatively large population study of
viral hepatitis in Jakarta 7 years ago have found only a
very small number of drug users in community.1 The
recent rise in the number of drug users in Indonesia may
change the proportion of viral hepatitis patients and its
influence in liver diseases in Indonesia.
We study the transaminases as an indication of liver
damage in heroin drug users addicts in connection with
the method of drugs usage (injection and non-injection)
and viral hepatitis infection.
MATERIAL AND METHOD
This study was done from March 1999 to July 1999
in a private hospital located in the center of Jakarta (Mitra
Menteng Abadi Hospital).  Data was collected consecu-
tively from patients who were admitted for rehabilitation
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or drug related complications with a positive urine test 
for heroin. Patients were excluded from the study if they 
had fever, serious illness, anti-HIV positive or on the 
multiple use of addictive drugs based on anamnesis and 
urinary test for multiple drugs. 
The hepatitis B surface antigen (HBsAg)   was ex- 
amined using reverse passive hemaglutination assay  
(RPHA) and the antibody of hepatitis C virus core-pro- 
tein (anti-HCV) with dipstick anti-HCV, anti-HIV with  
dipstick anti-HIV from Laboratorium Hepatika,  
Mataram, Indonesia.  The dipstick method for anti-HCV  
detection has been shown to have equal sensitivity to  
commonly used second-generation enzyme-linked  
immunosorbent assay.2 AST and ALT level were deter- 
mined using automatic chemical analyzer with cut-off  
value of 24 U/mL for AST and 27 U/mL for ALT.  
 Data was compiled and analyzed using Statistical  
Product and Service Solutions (SPSS) 7.5 for Windows  
(University of California Davis). Chi-square or Fisher  
exact test was applied to compare the value between  
the two groups. A significant level was assumed if p <  
0.05. 
RESULTS 
There were 162 patients, of these 133 (82 %) fulfill 
the criteria for study as described above. The patients 
characteristics are shown in table 1. 
Mean ALT and AST level in the injection group was  
higher than in the non-injection heroin addicts  (35.9 U/  
mL + 45.5 Vs 21.3 + 35.4 U/mL and 52.6 + 68.2 U/mL  
Vs 33.8 + 62.4 U/mL, respectively).   The ALT level  
was greater than the AST level in both groups showing  
that the hepatocellular damage were more likely to be in  
the acute phase. As showed in table 2, the numbers of  
patients with increased ALT and AST were significantly  
higher in the injection group compared to the non-injec- 
tion heroin addicts. Table 3 shows the AST and ALT  
value according to the virological status of the patients.  
 A significant difference of increased AST and ALT  
occurred in Anti-HCV positive compared to negative  
patients. But in the HBsAg group,  the number of pa- 
tients with increased AST and ALT was not different  
between the HBsAg negatives and positives.  
 The increase of transaminase was also consistent in  
injection drug user albeit there were no viral marker  
 
 
 
 
Table 1. All heroin addicts characteristics. 
 
n = 133 patients n % 
Sex :   male 118 88,7 
female 15 11,3 
Mean age (year) 21.1 + 3.7 
Mean duration of drug use (months) 27.9 + 19 
Method of drug use : injection 111 83,5 
non-injection 22 16,5 
Mean AST (U/L) +  SD 33.5 + 44.2 
Mean ALT (U/L) + SD 49.5 + 67.5 
HBsAg positive (%) 6 4,5 
Anti-HCV positive (%) 80 60.2 
HBsAg and Anti-HCV positive (%) 16 12 
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Table 2. Proportion of increase AST and ALT in injection and non-injection heroin addicts. 
 
Method of heroin 
usage 
AST  
 
ALT 
 
 increased normal  increased   normal 
Injection (%) 52 (39.1) 59 (44.4) 62 (46.6) 49 (36.8) 
Non-injection (%)  3 (2.3) 19 (14.3) 4 (3.0) 18 (13.5) 
p-value* 0.004 0.001 
* X2-test. 
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which could be detected. Table 4. shows the AST and
ALT level in patients with HBsAg negative and Anti-
HCV negative.
The number of patients with an increased level of
AST was significantly more than normal. Therefore, it
is possible that hepatocellular damage or dysfunction also
occurred in patients without hepatitis C or B infection
and other causes must be considered.
DISCUSSION
Transaminase is enzyme test that is usually performed
to asses the hepatocellular damage and AST and ALT
are the most frequently used tests for this reason. A rise
in these enzymes is implicated by the increase in cellular
damage or dysfunction in the liver. 3
Most of the drug users that we studied used heroin
by injection. They mixed the powder with non-sterilized
liquid. Heroin packages that are sold illegally in the street
are usually mixed with other substances that are not
completely known. Moreover, they usually share syringes
and needles with other drug users which are kept in non-
sterilized conditions which allow transmission of micro-
organisms. These can all be the reasons for the increased
transaminases, particularly in injection drug users as
shown in table 2.
The mean duration of heroin usage is about two years,
so they have been exposed to the damaging substances
for quiet some time. These patients will need a long term
follow up to ascertain the influence of this matter in the
future because of the chance of developing chronic liver
diseases.
Infection with hepatitis C but not hepatitis B virus is
strongly associated with hepatocellular damage in our
series. ALT levels were increased in 57.3 % (55/96 pa-
tients) with anti-HCV positive and more patients have
an increase of ALT than of AST which is more likely  to
indicate acute infection.3  More than half of the patients
with hepatitis C virus infection have increased ALT. Our
results were in-line with other studies.4  This may bring
problems in the future because in this kind of patient
liver disease tends to develop in to more severe liver
damage.5   Further-more, the normal ALT level in pa-
tients with anti-HCV positive must have a thorough pro-
spective investigation because the ALT level in hepatitis
C virus infection can fluctuate and this study revealed
that some of them are not completely free from hepato-
cellular damage.5,6
In the co-infection of hepatitis B and C viruses, the
transaminase also increased, that is suggestive of the
more explicit impact of hepatitis C virus infection be-
cause in the single hepatitis B virus infection, transami-
nases were normal . The expression of hepatitis B virus
is often masked with hepatitis C virus if the patient is co-
infected  but the risk of developing hepatocellular cancer
is much greater compared to a single infection with ei-
ther virus. 7,8
Table 3. AST and ALT value according to viral marker in heroin addicts (n = 133). 
 
  
Anti-HCV p* HBsAg p* 
  
negative positive  negative positive 
 
AST  normal (%) 28 (23.9) 42 (35.9) 0.017 66 (56.4) 4 (3.4) NS 
 increase (%) 9 (7.7) 46 (32.5)  45 (38.5) 2 (1.7)  
ALT  normal (%) 26 (22.2) 33 (28.2) 0.004 55 (47.0) 4 (3.4) NS 
 increase (%) 11 (9.4) 47 (40.2)  56 (47.9) 2 (1.7)  
* X2-test  
 
Table 4. ALT and AST value in heroin addicts with HBsAg and Anti-HCV 
negative (n = 31) 
 
 
AST ALT 
 
Increase Normal Increase Normal 
Injection (%) 7 (22.6) 12 (38.7) 8 (36.3) 11 (35.5) 
Non-injection (%) 0 12 (38.7) 1 (3.2) 11 (35.5) 
p* 0.017 NS 
X2-test. 
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The number of hepatitis B patients who were not co-
infected with hepatitis C virus is about the same to the
prevalence of hepatitis B infection in general population
1 
 suggested that they have the same route of transmis-
sion. In this kind of individual, the hepatitis B infection
usually occurred perinatally, therefore the transaminases
were not increased because of immune tolerance. Other
studies of hepatitis B in drug users also made the same
conclusion.9  Worth mentioning that is in adults, 80 - 90
% hepatitis B virus infection resulted in complete viral
clearance where HBsAg can not be detected anymore.
7
 In this study we used HBsAg as a marker only for
persistent infection of hepatitis B virus.
Viral infections were not the only cause of hepato-
cellular damage in drug users. The number of injection
drug users with raised transaminase particularly AST
was significantly higher than the normal one although no
viral marker had been detected. It is possible that they
have a seronegative viral infection or some other
hepatotropic viral infection which was not detected in
this study but  another possibility, such as hepatotoxicity
from an injected substance is worth  considering.  The
reason as to why the  AST and not the ALT is signifi-
cantly increased in IDU without HBsAg or Anti-HCV
is not clear but this pattern is somewhat different to the
pattern of increased transaminases in association with
hepatitis B or C virus infection, suggesting that a differ-
ent mechanism is involved.  This finding may be the re-
sult of chronic hepatocellular damage since AST was
shown to be increased more in chronic liver diseases
and  these patients have already used heroin by injection
for more than 6 months but the possibility of other organ
damage must be contemplated since AST is also found
in other organs such as heart.3
In conclusion, the examination of transaminases in
drug users, especially IDU is important because it is of-
ten increase with or without viral infection and it can be
a reflection of hepatocellular damage. Since the use of
drugs for detoxification and  to block endorphin recep-
tors can also have some degree of hepatotocicity, the
possibility of increased risk of drug induced hepatitis must
be considered. These drugs must be used judiciously in
IDU.
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